AI Analysis AI Analysis of BLRX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BLRX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Stronger technical forecast for BioLineRx Ltd. stock price after Friday trading
(Updated on Jun 26, 2026)

Sell candidate since Jun 25, 2026 Gain 1.60%

The BioLineRx Ltd. stock price gained 1.60% on the last trading day (Friday, 26th Jun 2026), rising from $3.12 to $3.17. During the last trading day the stock fluctuated 7.17% from a day low at $3.07 to a day high of $3.29. The price has been going up and down for this period, and there has been a -8.65% loss for the last 2 weeks. Volume fell on the last day by -14 thousand shares and in total, 6 thousand shares were bought and sold for approximately $19.40 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.11 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 44.65% during the next 3 months and, with a 90% probability hold a price between $4.49 and $6.04 at the end of this 3-month period.

BLRX Signals & Forecast

There are few to no technical positive signals at the moment. The BioLineRx Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $3.19 and $3.18. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, May 29, 2026, and so far it has fallen -16.14%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for BioLineRx Ltd. stock

BioLineRx Ltd. finds support from accumulated volume at $3.07 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.220 between high and low, or 7.17%. For the last week the stock has had daily average volatility of 8.92%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BLRX) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect BioLineRx Ltd. to open at $3.18, and during the day (based on 14 day Average True Range), to move between $3.04 and $3.30, which gives a possible trading interval of +/-$0.262 (+/-8.63%) up or down from last closing price. If BioLineRx Ltd. takes out the full calculated possible swing range there will be an estimated 8.63% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.07 (3.15%) than the resistance at $3.37 (6.31%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is BioLineRx Ltd. stock A Buy?

The BioLineRx Ltd. stock holds several negative signals and despite the positive trend, we believe BioLineRx Ltd. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.102 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $3.18 ( 0.210%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BLRX Performance

Trading levels for BLRX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.40 7.15%
R2 3.31 4.50%
R1 3.26 2.86%
Price 3.17
S1 3.09 -2.44%
S2 3.04 -4.08%
S3 2.96 -6.73%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.78 19.24%
R2 3.59 13.25%
R1 3.37 6.31%
Price 3.17
S1 3.07 -3.15%
S2 2.75 -13.25%
S3 2.63 -17.03%

FAQ

What is the symbol for BioLineRx Ltd. Stock and on which exchange is it traded?
The symbol for BioLineRx Ltd. is BLRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioLineRx Ltd. Stock?
The BioLineRx Ltd. stock holds several negative signals and despite the positive trend, we believe BioLineRx Ltd. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy BioLineRx Ltd. Stock?
BioLineRx Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioLineRx Ltd. Stock.

What's the current price of BioLineRx Ltd. Stock?
As of the end of day on the Jun 26, 2026, the price of an BioLineRx Ltd. (BLRX) share was $3.17.

What is the 52-week high and low for BioLineRx Ltd. Stock?
The 52-week high for BioLineRx Ltd. Stock is $4.92 and the 52-week low is $2.18.

What is the market capitalization of BioLineRx Ltd. Stock?
As of the Jun 26, 2026, the market capitalization of BioLineRx Ltd. is 13.772M.

When is the next earnings date for BioLineRx Ltd.?
The upcoming earnings date for BioLineRx Ltd. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT BIOLINERX LTD.
BioLineRx
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat...
GOLDEN STAR
Ticker Change Signal Date
JLL
$299.78
5.10% Jun 24
NMRK
$15.02
1.66% Jun 24
X
XMAX
$8.34
5.40% Jun 24
NESR
$25.07
12.64% Jun 23
TTEK
$28.04
4.35% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE